Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.

Nobécourt, E; Zeng, J; Davies, M J; Brown, B E; Yadav, S; Barter, P J; Rye, K-A

Nobécourt, E; Zeng, J; Davies, M J; Brown, B E; Yadav, S; Barter, P J; Rye, K-A.

Affiliation

Nobécourt E; Lipid Research Group, The Heart Research Institute, 145 Missenden Road, Camperdown, Sydney, NSW 2050, Australia.

Diabetologia ; 51(6): 1008-17, 2008 Jun.

Article in En | MEDLINE | ID: mdl-18437350

Subject(s)

Apolipoprotein A-I/blood; Cross-Linking Reagents/pharmacology; Apolipoprotein A-I/drug effects; Arginine/metabolism; Glycosylation; Guanidines/pharmacology; Humans; Lipoproteins, HDL/blood; Lipoproteins, HDL/drug effects; Lysine/metabolism; Metformin/pharmacology; Phosphatidylcholine-Sterol O-Acyltransferase/blood; Pyridoxamine/pharmacology; Pyruvaldehyde/pharmacology; Thiazoles/pharmacology; Tryptophan/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoprotein A-I / Cross-Linking Reagents Limits: Humans Language: En Journal: Diabetologia Year: 2008 Document type: Article Affiliation country: Australia Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google